本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Centessa Pharmaceuticals plc

24.15
+0.01000.04%
成交量:31.63萬
成交額:765.69萬
市值:32.38億
市盈率:-13.50
高:24.81
開:24.20
低:23.86
收:24.14
52周最高:24.81
52周最低:9.60
股本:1.34億
流通股本:8,495.06萬
量比:0.39
換手率:0.37%
股息:- -
股息率:- -
每股收益(TTM):-1.7885
每股收益(LYR):-2.0595
淨資產收益率:-72.92%
總資產收益率:-28.96%
市淨率:9.39
市盈率(LYR):-11.73

資料載入中...

2025/03/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/03/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/02/25

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/02/21

重要事件披露

Form 8-K - Current report
2025/02/20

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/02/19

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/02/14

[修訂]季度報告

Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
2025/02/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/02/07

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/02/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/02/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/27

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/21

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/08

重要事件披露

Form 8-K - Current report
2024/12/30

重要事件披露

Form 8-K - Current report
2024/12/26

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/12/20

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/12/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/12/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities